FDA
-
-
-
-
-
-
-
UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
-
-
-
-
-
-
-
Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting
-
-
-
-
-
-
-
Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
-
-
-
-
-
-
-
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
-
-
-
-
-
-
-
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
-
-
-
-
-
-
-
FDA approves Guardant Health test for Eli Lilly breast cancer drug
-
-
-
-
-
-
-
Guardant Health partners with PathGroup to expand Shield blood test access
-
330,549 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

